These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

122 related items for PubMed ID: 38431408

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Multifunctionalized Micelles Facilitate Intracellular Doxorubicin Delivery for Reversing Multidrug Resistance of Breast Cancer.
    Cao A, Ma P, Yang T, Lan Y, Yu S, Liu L, Sun Y, Liu Y.
    Mol Pharm; 2019 Jun 03; 16(6):2502-2510. PubMed ID: 30998372
    [Abstract] [Full Text] [Related]

  • 23. Micelles of d-α-Tocopheryl Polyethylene Glycol 2000 Succinate (TPGS 2K) for Doxorubicin Delivery with Reversal of Multidrug Resistance.
    Hao T, Chen D, Liu K, Qi Y, Tian Y, Sun P, Liu Y, Li Z.
    ACS Appl Mater Interfaces; 2015 Aug 19; 7(32):18064-75. PubMed ID: 26214761
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. A glutathione-responsive sulfur dioxide polymer prodrug as a nanocarrier for combating drug-resistance in cancer chemotherapy.
    Shen W, Liu W, Yang H, Zhang P, Xiao C, Chen X.
    Biomaterials; 2018 Sep 19; 178():706-719. PubMed ID: 29433753
    [Abstract] [Full Text] [Related]

  • 29. Ursolic acid augments the chemosensitivity of drug-resistant breast cancer cells to doxorubicin by AMPK-mediated mitochondrial dysfunction.
    Luo F, Zhao J, Liu S, Xue Y, Tang D, Yang J, Mei Y, Li G, Xie Y.
    Biochem Pharmacol; 2022 Nov 19; 205():115278. PubMed ID: 36191625
    [Abstract] [Full Text] [Related]

  • 30. Free Adriamycin-Loaded pH/Reduction Dual-Responsive Hyaluronic Acid-Adriamycin Prodrug Micelles for Efficient Cancer Therapy.
    Yin T, Wang Y, Chu X, Fu Y, Wang L, Zhou J, Tang X, Liu J, Huo M.
    ACS Appl Mater Interfaces; 2018 Oct 24; 10(42):35693-35704. PubMed ID: 30259743
    [Abstract] [Full Text] [Related]

  • 31. Pluronic-based functional polymeric mixed micelles for co-delivery of doxorubicin and paclitaxel to multidrug resistant tumor.
    Chen Y, Zhang W, Huang Y, Gao F, Sha X, Fang X.
    Int J Pharm; 2015 Jul 05; 488(1-2):44-58. PubMed ID: 25899286
    [Abstract] [Full Text] [Related]

  • 32. Tumor-targeting pH/redox dual-responsive nanosystem epigenetically reverses cancer drug resistance by co-delivering doxorubicin and GCN5 siRNA.
    Yuan Y, Liu J, Yu X, Liu X, Cheng Y, Zhou C, Li M, Shi L, Deng Y, Liu H, Wang G, Wang L, Wang Z.
    Acta Biomater; 2021 Nov 05; 135():556-566. PubMed ID: 34496281
    [Abstract] [Full Text] [Related]

  • 33. A hyaluronic acid modified cuprous metal-organic complex for reversing multidrug resistance via redox dyshomeostasis.
    Wan Y, Chen Z, Wang Y, Zhao W, Pei Z, Pu L, Lv Y, Li J, Li J, Pei Y.
    Carbohydr Polym; 2023 Jul 01; 311():120762. PubMed ID: 37028879
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Rational design of multifunctional micelles against doxorubicin-sensitive and doxorubicin-resistant MCF-7 human breast cancer cells.
    Hong W, Shi H, Qiao M, Gao X, Yang J, Tian C, Zhang D, Niu S, Liu M.
    Int J Nanomedicine; 2017 Jul 01; 12():989-1007. PubMed ID: 28243082
    [Abstract] [Full Text] [Related]

  • 37. Biocompatible cationic pullulan-g-desoxycholic acid-g-PEI micelles used to co-deliver drug and gene for cancer therapy.
    Chen L, Ji F, Bao Y, Xia J, Guo L, Wang J, Li Y.
    Mater Sci Eng C Mater Biol Appl; 2017 Jan 01; 70(Pt 1):418-429. PubMed ID: 27770912
    [Abstract] [Full Text] [Related]

  • 38. Redox-Responsive Polyphosphoester-Based Micellar Nanomedicines for Overriding Chemoresistance in Breast Cancer Cells.
    Ma YC, Wang JX, Tao W, Sun CY, Wang YC, Li DD, Fan F, Qian HS, Yang XZ.
    ACS Appl Mater Interfaces; 2015 Dec 02; 7(47):26315-25. PubMed ID: 26552849
    [Abstract] [Full Text] [Related]

  • 39. Trackable Mitochondria-Targeting Nanomicellar Loaded with Doxorubicin for Overcoming Drug Resistance.
    Zhang Y, Zhang C, Chen J, Liu L, Hu M, Li J, Bi H.
    ACS Appl Mater Interfaces; 2017 Aug 02; 9(30):25152-25163. PubMed ID: 28697306
    [Abstract] [Full Text] [Related]

  • 40. Reversal of multidrug resistance in breast cancer cells by a combination of ursolic acid with doxorubicin.
    Zong L, Cheng G, Liu S, Pi Z, Liu Z, Song F.
    J Pharm Biomed Anal; 2019 Feb 20; 165():268-275. PubMed ID: 30572191
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.